BackTNF Pharmaceuticals Overview

TNF Pharmaceuticals Accounts Payable

Track TNF Pharmaceuticals's accounts payable ($960K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$960308.00
↓ 55.64% YoYΔ $-1.20M vs prior year quarter

Peer trimmed avg / median

Loading

TNF Pharmaceuticals Accounts Payable History

Loading

TNF Pharmaceuticals vs. peers: Accounts Payable Comparison

Loading

TNF Pharmaceuticals Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

TNF Pharmaceuticals (TNFA) FAQ

TNF Pharmaceuticals (TNFA) currently reports a accounts payable of $960K as of March 2026. That compares with $2.2M in the prior-year period — down 55.6% year over year. Use the charts on this page to explore TNF Pharmaceuticals's accounts payable history and peer comparisons.

TNF Pharmaceuticals's accounts payable decreased from $2.2M to $960K — a 55.6% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

TNF Pharmaceuticals reported $960K in accounts payable as of March 2026. That compares with $2.2M in the prior-year period — down 55.6% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current accounts payable of $960K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for TNF Pharmaceuticals, and consider following TNFA for alerts when major investors trade the stock.